Table of Content

1 Antibody Drug Conjugate Market Overview
1.1 Antibody Drug Conjugate Product Overview
1.2 Antibody Drug Conjugate Market Segment by Type
1.2.1 Adcetris
1.2.2 Kadcyl
1.2.3 Other
1.3 Global Antibody Drug Conjugate Market Size by Type
1.3.1 Global Antibody Drug Conjugate Market Size Overview by Type (2018-2034)
1.3.2 Global Antibody Drug Conjugate Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antibody Drug Conjugate Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antibody Drug Conjugate Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antibody Drug Conjugate Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antibody Drug Conjugate Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antibody Drug Conjugate Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antibody Drug Conjugate Sales Breakdown by Type (2018-2024)
2 Global Antibody Drug Conjugate Market Competition by Company
2.1 Global Top Players by Antibody Drug Conjugate Sales (2018-2024)
2.2 Global Top Players by Antibody Drug Conjugate Revenue (2018-2024)
2.3 Global Top Players by Antibody Drug Conjugate Price (2018-2024)
2.4 Global Top Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antibody Drug Conjugate Market Competitive Situation and Trends
2.5.1 Antibody Drug Conjugate Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antibody Drug Conjugate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugate as of 2022)
2.7 Date of Key Manufacturers Enter into Antibody Drug Conjugate Market
2.8 Key Manufacturers Antibody Drug Conjugate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antibody Drug Conjugate Status and Outlook by Region
3.1 Global Antibody Drug Conjugate Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Antibody Drug Conjugate Historic Market Size by Region
3.2.1 Global Antibody Drug Conjugate Sales in Volume by Region (2018-2024)
3.2.2 Global Antibody Drug Conjugate Sales in Value by Region (2018-2024)
3.2.3 Global Antibody Drug Conjugate Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antibody Drug Conjugate Forecasted Market Size by Region
3.3.1 Global Antibody Drug Conjugate Sales in Volume by Region (2024-2034)
3.3.2 Global Antibody Drug Conjugate Sales in Value by Region (2024-2034)
3.3.3 Global Antibody Drug Conjugate Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antibody Drug Conjugate by Application
4.1 Antibody Drug Conjugate Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmaceutical Company
4.1.3 Research Institutions
4.2 Global Antibody Drug Conjugate Market Size by Application
4.2.1 Global Antibody Drug Conjugate Market Size Overview by Application (2018-2034)
4.2.2 Global Antibody Drug Conjugate Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antibody Drug Conjugate Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antibody Drug Conjugate Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antibody Drug Conjugate Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antibody Drug Conjugate Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antibody Drug Conjugate Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antibody Drug Conjugate Sales Breakdown by Application (2018-2024)
5 North America Antibody Drug Conjugate by Country
5.1 North America Antibody Drug Conjugate Historic Market Size by Country
5.1.1 North America Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Antibody Drug Conjugate Sales in Volume by Country (2018-2024)
5.1.3 North America Antibody Drug Conjugate Sales in Value by Country (2018-2024)
5.2 North America Antibody Drug Conjugate Forecasted Market Size by Country
5.2.1 North America Antibody Drug Conjugate Sales in Volume by Country (2024-2034)
5.2.2 North America Antibody Drug Conjugate Sales in Value by Country (2024-2034)
6 Europe Antibody Drug Conjugate by Country
6.1 Europe Antibody Drug Conjugate Historic Market Size by Country
6.1.1 Europe Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Antibody Drug Conjugate Sales in Volume by Country (2018-2024)
6.1.3 Europe Antibody Drug Conjugate Sales in Value by Country (2018-2024)
6.2 Europe Antibody Drug Conjugate Forecasted Market Size by Country
6.2.1 Europe Antibody Drug Conjugate Sales in Volume by Country (2024-2034)
6.2.2 Europe Antibody Drug Conjugate Sales in Value by Country (2024-2034)
7 Asia-Pacific Antibody Drug Conjugate by Region
7.1 Asia-Pacific Antibody Drug Conjugate Historic Market Size by Region
7.1.1 Asia-Pacific Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Antibody Drug Conjugate Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antibody Drug Conjugate Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antibody Drug Conjugate Forecasted Market Size by Region
7.2.1 Asia-Pacific Antibody Drug Conjugate Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antibody Drug Conjugate Sales in Value by Region (2024-2034)
8 Latin America Antibody Drug Conjugate by Country
8.1 Latin America Antibody Drug Conjugate Historic Market Size by Country
8.1.1 Latin America Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Antibody Drug Conjugate Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antibody Drug Conjugate Sales in Value by Country (2018-2024)
8.2 Latin America Antibody Drug Conjugate Forecasted Market Size by Country
8.2.1 Latin America Antibody Drug Conjugate Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antibody Drug Conjugate Sales in Value by Country (2024-2034)
9 Middle East and Africa Antibody Drug Conjugate by Country
9.1 Middle East and Africa Antibody Drug Conjugate Historic Market Size by Country
9.1.1 Middle East and Africa Antibody Drug Conjugate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Antibody Drug Conjugate Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antibody Drug Conjugate Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antibody Drug Conjugate Forecasted Market Size by Country
9.2.1 Middle East and Africa Antibody Drug Conjugate Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antibody Drug Conjugate Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Seattle Genetics/Takeda
10.1.1 Seattle Genetics/Takeda Company Information
10.1.2 Seattle Genetics/Takeda Introduction and Business Overview
10.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Products Offered
10.1.5 Seattle Genetics/Takeda Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche Antibody Drug Conjugate Products Offered
10.2.5 Roche Recent Development
10.3 ImmunoGen
10.3.1 ImmunoGen Company Information
10.3.2 ImmunoGen Introduction and Business Overview
10.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ImmunoGen Antibody Drug Conjugate Products Offered
10.3.5 ImmunoGen Recent Development
10.4 Immunomedics
10.4.1 Immunomedics Company Information
10.4.2 Immunomedics Introduction and Business Overview
10.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Immunomedics Antibody Drug Conjugate Products Offered
10.4.5 Immunomedics Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Antibody Drug Conjugate Products Offered
10.5.5 Pfizer Recent Development
10.6 Celldex Therapeutics
10.6.1 Celldex Therapeutics Company Information
10.6.2 Celldex Therapeutics Introduction and Business Overview
10.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Celldex Therapeutics Antibody Drug Conjugate Products Offered
10.6.5 Celldex Therapeutics Recent Development
10.7 Millennium Pharmaceuticals
10.7.1 Millennium Pharmaceuticals Company Information
10.7.2 Millennium Pharmaceuticals Introduction and Business Overview
10.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Products Offered
10.7.5 Millennium Pharmaceuticals Recent Development
10.8 Bayer HealthCare
10.8.1 Bayer HealthCare Company Information
10.8.2 Bayer HealthCare Introduction and Business Overview
10.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bayer HealthCare Antibody Drug Conjugate Products Offered
10.8.5 Bayer HealthCare Recent Development
10.9 Mersana Therapeutics
10.9.1 Mersana Therapeutics Company Information
10.9.2 Mersana Therapeutics Introduction and Business Overview
10.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mersana Therapeutics Antibody Drug Conjugate Products Offered
10.9.5 Mersana Therapeutics Recent Development
10.10 Heidelberg Pharma
10.10.1 Heidelberg Pharma Company Information
10.10.2 Heidelberg Pharma Introduction and Business Overview
10.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Heidelberg Pharma Antibody Drug Conjugate Products Offered
10.10.5 Heidelberg Pharma Recent Development
10.11 Oxford BioTherapeutics
10.11.1 Oxford BioTherapeutics Company Information
10.11.2 Oxford BioTherapeutics Introduction and Business Overview
10.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Products Offered
10.11.5 Oxford BioTherapeutics Recent Development
10.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Company Information
10.12.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Products Offered
10.12.5 Takeda Pharmaceutical Company Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antibody Drug Conjugate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antibody Drug Conjugate Industrial Chain Analysis
11.4 Antibody Drug Conjugate Market Dynamics
11.4.1 Antibody Drug Conjugate Industry Trends
11.4.2 Antibody Drug Conjugate Market Drivers
11.4.3 Antibody Drug Conjugate Market Challenges
11.4.4 Antibody Drug Conjugate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antibody Drug Conjugate Distributors
12.3 Antibody Drug Conjugate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adcetris
Table 2. Major Company of Kadcyl
Table 3. Major Company of Other
Table 4. Global Antibody Drug Conjugate Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Antibody Drug Conjugate Sales by Type (2018-2024) & (K Units)
Table 6. Global Antibody Drug Conjugate Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Antibody Drug Conjugate Sales by Type (2018-2024) & (US& Million)
Table 8. Global Antibody Drug Conjugate Market Share in Value by Type (2018-2024)
Table 9. Global Antibody Drug Conjugate Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Antibody Drug Conjugate Sales by Type (2024-2034) & (K Units)
Table 11. Global Antibody Drug Conjugate Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Antibody Drug Conjugate Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Antibody Drug Conjugate Sales Market Share in Value by Type (2024-2034)
Table 14. Global Antibody Drug Conjugate Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Antibody Drug Conjugate Sales by Type (2018-2024) & (K Units)
Table 16. North America Antibody Drug Conjugate Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Antibody Drug Conjugate Sales (K Units) by Type (2018-2024)
Table 18. Europe Antibody Drug Conjugate Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Antibody Drug Conjugate Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Antibody Drug Conjugate Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Antibody Drug Conjugate Sales (K Units) by Type (2018-2024)
Table 22. Latin America Antibody Drug Conjugate Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Antibody Drug Conjugate Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Antibody Drug Conjugate Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Antibody Drug Conjugate Sales by Company (2018-2024) & (K Units)
Table 26. Global Antibody Drug Conjugate Sales Share by Company (2018-2024)
Table 27. Global Antibody Drug Conjugate Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Antibody Drug Conjugate Revenue Share by Company (2018-2024)
Table 29. Global Market Antibody Drug Conjugate Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Antibody Drug Conjugate Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Antibody Drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody Drug Conjugate as of 2022)
Table 33. Date of Key Manufacturers Enter into Antibody Drug Conjugate Market
Table 34. Key Manufacturers Antibody Drug Conjugate Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Antibody Drug Conjugate Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Antibody Drug Conjugate Sales by Region (2018-2024) & (K Units)
Table 38. Global Antibody Drug Conjugate Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Antibody Drug Conjugate Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Antibody Drug Conjugate Sales Market Share in Value by Region (2018-2024)
Table 41. Global Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Antibody Drug Conjugate Sales by Region (2024-2034) & (K Units)
Table 43. Global Antibody Drug Conjugate Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Antibody Drug Conjugate Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Antibody Drug Conjugate Sales Market Share in Value by Region (2024-2034)
Table 46. Global Antibody Drug Conjugate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Antibody Drug Conjugate Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Antibody Drug Conjugate Sales by Application (2018-2024) & (K Units)
Table 49. Global Antibody Drug Conjugate Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Antibody Drug Conjugate Sales Market Share in Value by Application (2018-2024)
Table 52. Global Antibody Drug Conjugate Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Antibody Drug Conjugate Sales by Application (2024-2034) & (K Units)
Table 54. Global Antibody Drug Conjugate Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Antibody Drug Conjugate Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Antibody Drug Conjugate Sales Market Share in Value by Application (2024-2034)
Table 57. Global Antibody Drug Conjugate Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Antibody Drug Conjugate Sales by Application (2018-2024) (K Units)
Table 59. North America Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Antibody Drug Conjugate Sales by Application (2018-2024) (K Units)
Table 61. Europe Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Antibody Drug Conjugate Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Antibody Drug Conjugate Sales by Application (2018-2024) (K Units)
Table 65. Latin America Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Antibody Drug Conjugate Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Antibody Drug Conjugate Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Antibody Drug Conjugate Sales by Country (2018-2024) & (K Units)
Table 69. North America Antibody Drug Conjugate Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Antibody Drug Conjugate Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Antibody Drug Conjugate Sales Market Share in Value by Country (2018-2024)
Table 72. North America Antibody Drug Conjugate Sales by Country (2024-2034) & (K Units)
Table 73. North America Antibody Drug Conjugate Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Antibody Drug Conjugate Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Antibody Drug Conjugate Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Antibody Drug Conjugate Sales by Country (2018-2024) & (K Units)
Table 77. Europe Antibody Drug Conjugate Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Antibody Drug Conjugate Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Antibody Drug Conjugate Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Antibody Drug Conjugate Sales by Country (2024-2034) & (K Units)
Table 81. Europe Antibody Drug Conjugate Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Antibody Drug Conjugate Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Antibody Drug Conjugate Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Antibody Drug Conjugate Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Antibody Drug Conjugate Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Antibody Drug Conjugate Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Antibody Drug Conjugate Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Antibody Drug Conjugate Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Antibody Drug Conjugate Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Antibody Drug Conjugate Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Antibody Drug Conjugate Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Antibody Drug Conjugate Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Antibody Drug Conjugate Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Antibody Drug Conjugate Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Antibody Drug Conjugate Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Antibody Drug Conjugate Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Antibody Drug Conjugate Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Antibody Drug Conjugate Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Antibody Drug Conjugate Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Value by Country (2024-2034)
Table 108. Seattle Genetics/Takeda Company Information
Table 109. Seattle Genetics/Takeda Introduction and Business Overview
Table 110. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Seattle Genetics/Takeda Antibody Drug Conjugate Product
Table 112. Seattle Genetics/Takeda Recent Development
Table 113. Roche Company Information
Table 114. Roche Introduction and Business Overview
Table 115. Roche Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Roche Antibody Drug Conjugate Product
Table 117. Roche Recent Development
Table 118. ImmunoGen Company Information
Table 119. ImmunoGen Introduction and Business Overview
Table 120. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. ImmunoGen Antibody Drug Conjugate Product
Table 122. ImmunoGen Recent Development
Table 123. Immunomedics Company Information
Table 124. Immunomedics Introduction and Business Overview
Table 125. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Immunomedics Antibody Drug Conjugate Product
Table 127. Immunomedics Recent Development
Table 128. Pfizer Company Information
Table 129. Pfizer Introduction and Business Overview
Table 130. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Pfizer Antibody Drug Conjugate Product
Table 132. Pfizer Recent Development
Table 133. Celldex Therapeutics Company Information
Table 134. Celldex Therapeutics Introduction and Business Overview
Table 135. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Celldex Therapeutics Antibody Drug Conjugate Product
Table 137. Celldex Therapeutics Recent Development
Table 138. Millennium Pharmaceuticals Company Information
Table 139. Millennium Pharmaceuticals Introduction and Business Overview
Table 140. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Millennium Pharmaceuticals Antibody Drug Conjugate Product
Table 142. Millennium Pharmaceuticals Recent Development
Table 143. Bayer HealthCare Company Information
Table 144. Bayer HealthCare Introduction and Business Overview
Table 145. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Bayer HealthCare Antibody Drug Conjugate Product
Table 147. Bayer HealthCare Recent Development
Table 148. Mersana Therapeutics Company Information
Table 149. Mersana Therapeutics Introduction and Business Overview
Table 150. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Mersana Therapeutics Antibody Drug Conjugate Product
Table 152. Mersana Therapeutics Recent Development
Table 153. Heidelberg Pharma Company Information
Table 154. Heidelberg Pharma Introduction and Business Overview
Table 155. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Heidelberg Pharma Antibody Drug Conjugate Product
Table 157. Heidelberg Pharma Recent Development
Table 158. Oxford BioTherapeutics Company Information
Table 159. Oxford BioTherapeutics Introduction and Business Overview
Table 160. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Oxford BioTherapeutics Antibody Drug Conjugate Product
Table 162. Oxford BioTherapeutics Recent Development
Table 163. Takeda Pharmaceutical Company Limited Company Information
Table 164. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 165. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product
Table 167. Takeda Pharmaceutical Company Limited Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Antibody Drug Conjugate Market Trends
Table 171. Antibody Drug Conjugate Market Drivers
Table 172. Antibody Drug Conjugate Market Challenges
Table 173. Antibody Drug Conjugate Market Restraints
Table 174. Antibody Drug Conjugate Distributors List
Table 175. Antibody Drug Conjugate Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Drug Conjugate Product Picture
Figure 2. Global Antibody Drug Conjugate Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antibody Drug Conjugate Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Antibody Drug Conjugate Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Adcetris
Figure 6. Global Adcetris Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Kadcyl
Figure 8. Global Kadcyl Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Antibody Drug Conjugate Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Antibody Drug Conjugate Sales Market Share by Type in 2022 & 2034
Figure 13. North America Antibody Drug Conjugate Sales Market Share in Volume by Type in 2022
Figure 14. North America Antibody Drug Conjugate Sales Market Share in Value by Type in 2022
Figure 15. Europe Antibody Drug Conjugate Sales Market Share in Volume by Type in 2022
Figure 16. Europe Antibody Drug Conjugate Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Value by Type in 2022
Figure 19. Latin America Antibody Drug Conjugate Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Antibody Drug Conjugate Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Drug Conjugate Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Drug Conjugate Revenue in 2022
Figure 25. Antibody Drug Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Pharmaceutical Company
Figure 29. Global Pharmaceutical Company Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Research Institutions
Figure 31. Global Research Institutions Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Antibody Drug Conjugate Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Antibody Drug Conjugate Sales Market Share by Application in 2022 & 2034
Figure 34. North America Antibody Drug Conjugate Sales Market Share in Volume by Application in 2022
Figure 35. North America Antibody Drug Conjugate Sales Market Share in Value by Application in 2022
Figure 36. Europe Antibody Drug Conjugate Sales Market Share in Volume by Application in 2022
Figure 37. Europe Antibody Drug Conjugate Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Antibody Drug Conjugate Sales Market Share in Value by Application in 2022
Figure 40. Latin America Antibody Drug Conjugate Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Antibody Drug Conjugate Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Antibody Drug Conjugate Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Antibody Drug Conjugate Manufacturing Cost Structure
Figure 45. Antibody Drug Conjugate Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed